HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell surface antigen in bilharzial bladder tumours.

Abstract
Detection of the ABO (H) blood group in the urothelium in cases of transitional cell carcinoma of the bladder is a good indicator of the future behaviour of these tumours. Since conventional histopathological and clinical examination in bilharzial bladder carcinoma shows a clinical staging error rate of 37.2%, we used the specific red cell adherence (SRCA) technique to study the cell surface antigens in 28 patients over a 5-year period. A prediction rate of 63.6 to 84.6% was obtained when correlated with clinical behaviour.
AuthorsA Halim, N Javadpour, A Kasraeian, J D Young
JournalBritish journal of urology (Br J Urol) Vol. 58 Issue 5 Pg. 523-5 (Oct 1986) ISSN: 0007-1331 [Print] England
PMID3096417 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ABO Blood-Group System
  • Antigens, Neoplasm
  • Antigens, Surface
Topics
  • ABO Blood-Group System (immunology)
  • Antigens, Neoplasm (analysis)
  • Antigens, Surface (analysis)
  • Humans
  • Prognosis
  • Schistosomiasis haematobia (complications, immunology)
  • Urinary Bladder Neoplasms (complications, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: